Canyon Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$89.7M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$69.6M |
| 3 |
Tenet Healthcare
THC
|
+$44M |
| 4 |
Liberty Latin America Class C
LILAK
|
+$36.1M |
| 5 |
GSEVU
Gores Holdings VII, Inc. Units
GSEVU
|
+$34.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caesars Entertainment
CZR
|
+$215M |
| 2 |
Dell
DELL
|
+$151M |
| 3 |
VICI Properties
VICI
|
+$96.9M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$92.5M |
| 5 |
Howmet Aerospace
HWM
|
+$62.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.52% |
| 2 | Materials | 9.62% |
| 3 | Consumer Discretionary | 7.74% |
| 4 | Healthcare | 7.29% |
| 5 | Financials | 5.99% |
Similar funds
Canyon Capital Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Canyon Capital Advisors held 97 positions worth $2.52B, up 8.8% from $2.32B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Canyon Capital Advisors withdrew a net $625M in Q1 2021, closing 7 positions and reducing 10 holdings. Its most notable exit was VICI Properties, an estimated $96.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Materials and Consumer Discretionary.
Against the trend, Canyon Capital Advisors opened a new position in Alexion Pharmaceuticals worth $68.8M.
- Canyon Capital Advisors's largest Q1 2021 buy was Alexion Pharmaceuticals: 450,000 shares worth $68.8M.
- Canyon Capital Advisors added most to Xilinx Inc in Q1 2021, an estimated $89.7M increase.
- Canyon Capital Advisors's biggest Q1 2021 reduction was Caesars Entertainment, cutting an estimated $215M.
- Canyon Capital Advisors fully exited VICI Properties in Q1 2021, selling an estimated $96.9M.
- Canyon Capital Advisors's ten largest holdings make up 55% of its $2.52B portfolio in Q1 2021.
- Canyon Capital Advisors opened 51 new positions and closed 7 in Q1 2021.
- Canyon Capital Advisors's portfolio value rose 8.8% quarter-over-quarter to $2.52B.
Based on Canyon Capital Advisors's 13F filing for Q1 2021, filed 17 May 2021.